Endonovo Thereputics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Hanover Portfolio Acquisitions Inc Signs Letter of Intent To Acquire The Aviva Companies Corporation
Hanover Portfolio Acquisitions Inc announced it has signed a Letter of Intent to acquire 100% of The Aviva Companies Corporation. The Aviva Companies is a Texas-based company focused on the transfer and commercialization of intellectual property developed primarily in Israel. Financial terms were not disclosed.
Latest Developments for Endonovo Thereputics Inc
- Hanover Portfolio Acquisitions Inc Announces Acquisition Of WeHealAnimals, Inc
- Hanover Portfolio Acquisitions Inc Completes Acquisition Of The Aviva Companies Corporation
- Hanover Portfolio Acquisitions Inc Signs Letter Of Intent To Acquire Tigga Studios
- Hanover Portfolio Acquisitions Inc Signs Letter of Intent to Acquire Pain Management Medical Device Company
Latest Key Developments in Biotechnology
- Omeros Corp prices $35.0 million public offering of common stock
- Navidea Biopharmaceuticals Inc announces presentation of Lymphoseek three-year recurrence and survival outcomes after Sentinel Lymph Node Biopsy in Patients with Breast Cancer and Melanoma
- Algeta appoints Thomas Ramdahl as new Managing Director
- Algeta ASA appoints chairman; to apply for delisting of shares from Oslo Stock Exchange
- Share this
- Digg this